SIH-538
Montelukast
Eine Lieferung in diese Region ist nicht möglich.
- SKU:
- SIH-538
- Zusätzliche Namen:
- 1-[[[(1R)-1-[3-(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]-methyl]-cyclopropaneacetic acid, monosodium salt, Montelukast sodium, Montelukast monosodium salt, MK-0476, MK-476, KS-1087
- Molekulargewicht:
- 608.2
- Reinheit:
- >98%
- Quelle:
- Synthetic
- Lagerbedingungen:
- -20[o]C
- Hersteller:
- StressMarq Biosciences
- CAS Number:
- 151767-02-1
- ABP:
- No Import Docs
- Weitere Details:
- Montelukast sodium, a selective cysteinyl leukotriene receptor 1 (CysLT1) antagonist, is gaining attention in neuroscience for its neuroprotective and anti-inflammatory properties. Originally developed for asthma and allergic rhinitis, Montelukast has demonstrated the ability to cross the blood-brain barrier and modulate neuroinflammatory responses. In preclinical models, it has been shown to reduce blood-brain barrier disruption, inhibit leukocyte migration, and suppress seizure activity. These effects suggest potential therapeutic applications in neurodegenerative diseases such as Alzheimer's and Parkinson's, where inflammation and barrier dysfunction are key pathological features.
- Versandbedingungen:
- Ambient